FITC-C6-LEHD-FMK

FITC-C6-LEHD-FMK

• UNSPSC Description: FITC-C6-LEHD-FMK, a fluorescently labeled caspase-9 inhibitor, can be used for detection of active caspase-9 in mammalian cells undergoing apoptosis. FITC-C6-LEHD-FMK provides a convenient means for sensitive detection of activated caspase-9 in living cells. Z-LEHD-FMK is a specific caspase-9 inhibitor[1].
• Target Antigen: Fluorescent Dye
• Type: Dye Reagents
• Related Pathways: Others
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/fitc-c6-lehd-fmk.html
• Solubility: 10 mM in DMSO
• Smiles: O=C1C=CC(C(O2)=C1)=C(C3=C(C(O)=O)C=C(NC(NCCCCCC(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC4=CN=CN4)C(N[C@@H](CC(O)=O)C(CF)=O)=O)=O)=O)=O)=S)C=C3)C5=C2C=C(O)C=C5
• Molecular Weight: 1031.07
• References & Citations: [1]Ozoren N, et, al. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 2000 Nov 15; 60(22): 6259-65.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported